Kevin Tan
Equibles does not estimate personal net worth.
Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RNAC alertsAbout Kevin Tan
Kevin Tan is recorded as CFO at Cartesian Therapeutics, Inc. (RNAC). The proxy statement of Cartesian Therapeutics, Inc. reports total compensation of $1,688,429 for Kevin Tan in fiscal 2022, including a base salary of $425,769. Disclosed compensation is on record for 2 fiscal years. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Carsten Brunn, Ph.D. (Chairman), Blaine Davis (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Cartesian Therapeutics, Inc.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Carrie S. Cox Board Member
- Kemal Malik Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Cartesian Therapeutics, Inc. (RNAC) | Former Chief Financial Officer | $425,769 | $1,688,429 |
| 2021 | Cartesian Therapeutics, Inc. (RNAC) | Former Chief Financial Officer | $110,385 | $2,601,622 |
Recent activity
No call appearances or filed executive changes recorded yet.